These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2396995)

  • 1. Kinetics of inhibition of platelet calpain II by human kininogens.
    Bradford HN; Schmaier AH; Colman RW
    Biochem J; 1990 Aug; 270(1):83-90. PubMed ID: 2396995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low molecular weight kininogen binds to platelets to modulate thrombin-induced platelet activation.
    Meloni FJ; Schmaier AH
    J Biol Chem; 1991 Apr; 266(11):6786-94. PubMed ID: 2016293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High molecular weight kininogen is an inhibitor of platelet calpain.
    Schmaier AH; Bradford H; Silver LD; Farber A; Scott CF; Schutsky D; Colman RW
    J Clin Invest; 1986 May; 77(5):1565-73. PubMed ID: 2422211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contiguous binding and inhibitory sites on kininogens required for the inhibition of platelet calpain.
    Bradford HN; Jameson BA; Adam AA; Wassell RP; Colman RW
    J Biol Chem; 1993 Dec; 268(35):26546-51. PubMed ID: 8253784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High molecular weight kininogen binds to platelets by its heavy and light chains and when bound has altered susceptibility to kallikrein cleavage.
    Meloni FJ; Gustafson EJ; Schmaier AH
    Blood; 1992 Mar; 79(5):1233-44. PubMed ID: 1536948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-molecular-mass and low-molecular-mass kininogens block plasmin-induced platelet aggregation by forming a complex with kringle 5 of plasminogen/plasmin.
    Selim TE; Ghoneim HR; Uknis AB; Colman RW; DeLa Cadena RA
    Eur J Biochem; 1997 Dec; 250(2):532-8. PubMed ID: 9428707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of thrombin-induced platelet aggregation by inhibition of calpain by a synthetic peptide derived from the thiol-protease inhibitory sequence of kininogens and S-(3-nitro-2-pyridinesulfenyl)-cysteine.
    Puri RN; Matsueda R; Umeyama H; Bradford HN; Colman RW
    Eur J Biochem; 1993 May; 214(1):233-41. PubMed ID: 8389701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of the bifunctional properties of high molecular weight kininogen by studies with monoclonal antibodies directed to each of its chains.
    Schmaier AH; Schutsky D; Farber A; Silver LD; Bradford HN; Colman RW
    J Biol Chem; 1987 Jan; 262(3):1405-11. PubMed ID: 2433279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights on monoclonal antibodies to kininogens' heavy chain which influence kininogens' binding to platelets.
    Jiang Y; Nawarawong W; Meloni FJ; Schmaier AH
    Thromb Haemost; 1992 Aug; 68(2):143-8. PubMed ID: 1412158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of thrombospondin 1 on the surface of activated platelets mediates their interaction with the heavy chains of human kininogens through Lys 244-Pro 254.
    DeLa Cadena RA; Kunapuli SP; Walz DA; Colman RW
    Thromb Haemost; 1998 Jan; 79(1):186-94. PubMed ID: 9459346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bradykinin regulates the expression of kininogen binding sites on endothelial cells.
    Zini JM; Schmaier AH; Cines DB
    Blood; 1993 Jun; 81(11):2936-46. PubMed ID: 8388750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress curve analysis of the kinetics with which blood coagulation factor XIa is inhibited by protease nexin-2.
    Scandura JM; Zhang Y; Van Nostrand WE; Walsh PN
    Biochemistry; 1997 Jan; 36(2):412-20. PubMed ID: 9003194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of chicken calpain II by proteins of the cystatin superfamily and alpha 2-macroglobulin.
    Crawford C
    Biochem J; 1987 Dec; 248(2):589-94. PubMed ID: 2449169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The carboxyl terminus of bradykinin and amino terminus of the light chain of kininogens comprise an endothelial cell binding domain.
    Hasan AA; Cines DB; Zhang J; Schmaier AH
    J Biol Chem; 1994 Dec; 269(50):31822-30. PubMed ID: 7989355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of human calpains I and II with high molecular weight and low molecular weight kininogens and their heavy chain: mechanism of interaction and the role of divalent cations.
    Ishiguro H; Higashiyama S; Namikawa C; Kunimatsu M; Takano E; Tanaka K; Ohkubo I; Murachi T; Sasaki M
    Biochemistry; 1987 May; 26(10):2863-70. PubMed ID: 3038169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteolytic degradation of high molecular weight kininogen in acute thrombotic thrombocytopenic purpura.
    Pavord S; Kelton JG; Warner MN; Moore JC; Warkentin TE; Hayward CP
    Br J Haematol; 1997 Jun; 97(4):762-7. PubMed ID: 9217174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposing effects of low and high molecular weight kininogens on cell adhesion.
    Asakura S; Yang W; Sottile J; Zhang Q; Jin Y; Ohkubo I; Sasaki M; Matsuda M; Hirata H; Mosher DF
    J Biochem; 1998 Sep; 124(3):473-84. PubMed ID: 9722655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of cell binding and thrombin inhibitory regions on kininogens' heavy chain.
    Jiang YP; Schmaier AH
    Agents Actions Suppl; 1992; 38 ( Pt 1)():233-40. PubMed ID: 1466275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of a kininogen-based selective inhibitor of thrombin-induced platelet aggregation.
    Matsueda R; Umeyama H; Puri RN; Bradford HN; Colman RW
    Pept Res; 1994; 7(1):32-5. PubMed ID: 8019060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics of the kininogens.
    Schmaier AH; Wahl R; Fisher SJ; Brenner D
    Thromb Res; 1998 Dec; 92(6):293-7. PubMed ID: 9870897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.